Ovarian Cancer | Tumor

CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.

Making Metastatic Cancer Fears Work for Me

April 24th 2018, 10:15pm

Article

So, what was the first thing I thought about when I vowed to not think about cancer? Cancer, of course.

FDA Approves First Assay to Identify Rubraca Benefit Among Women with Ovarian Cancer

April 24th 2018, 5:48pm

Article

The Food and Drug Administration (FDA) approved a next-generation sequencing (NGS) companion diagnostic assay that can detect BRCA1/2 genetic mutations, as well as the percentage of genomic loss of heterozygosity (LOH) in patients with ovarian cancer.

23andMe Test Opens Conversations, Highlights Need for Genetic Counselors

April 23rd 2018, 11:33pm

Article

Albeit growing popularity of at-home genetic testing, it is still necessary to seek professional medical opinions from genetic counselors to help discuss results.

Debunking Clinical Trial Myths

April 23rd 2018, 11:17pm

Video

Many patients with ovarian cancer have misconceptions about the care they will receive while on a clinical trial, according to Laurel W. Rice, M.D.

Patrick Dempsey on Complementary Therapies

April 17th 2018, 8:05pm

Article

Yoga and Reiki can have great benefits for patients undergoing cancer treatment, according to Patrick Dempsey.

A Candid Conversation With Patrick Dempsey

April 12th 2018, 4:00pm

Podcast

Patrick Dempsey, actor, cancer advocate and Breakaway From Cancer® Ambassador, sat down with CURE® to discuss how cancer impacted his life after his mother was diagnosed with ovarian cancer.

Thinking Outside Cancer's Box

April 11th 2018, 6:17pm

Article

Cancer is a serious business. But who said it needs to be a business of seriousness?

More May Benefit from PARP Inhibitors Through Drug Combinations

April 10th 2018, 10:00pm

Article

PARP inhibitors are continuing to create buzz in the ovarian cancer space, both as single agents and in combinations that are currently being examined in clinical trials.

FDA Approves Rubraca for Maintenance Ovarian Cancer Treatment

April 6th 2018, 9:43pm

Article

The Food and Drug Administration (FDA) approved Rubraca (rucaparib) as a maintenance therapy for women with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer who are in complete or partial response to platinum-based chemotherapy, according to Clovis Oncology, the company that manufactures the drug.

PARP-7 Protein May Significantly Improve Ovarian Cancer Survival

April 5th 2018, 7:23pm

Article

Despite exciting developments of PARP inhibitors over the years, limited knowledge exists in the mechanism of PARP-7 and its potential effect in targeted therapy for patients with ovarian cancer.